Loading...
•
May 31
Walgreens Q3 2025 Earnings Report
Walgreens reported Q3 results with a net loss and lower adjusted EPS driven by higher taxes and weaker retail sales.
Key Takeaways
Walgreens delivered $39.0B in revenue for Q3 2025, growing year-over-year. However, it posted a net loss of $175M due to prior year gains not recurring and higher tax expenses. Adjusted EPS dropped to $0.38 as cost savings were offset by weaker retail sales and lower equity earnings.
Q3 revenue grew 7.2% year-over-year to $39.0B
Reported a net loss of $175M vs. net income of $344M in Q3 2024
Adjusted EPS declined to $0.38 from $0.63
Free cash flow remained positive at $336M
Walgreens
Walgreens
Walgreens Revenue by Segment
Walgreens Revenue by Geographic Location
Revenue by Segment
U.S. Pharmacy Revenue
CapyFin.comInternational Revenue
CapyFin.comU.S. Healthcare Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Fiscal 2025 guidance remains withdrawn due to the pending Sycamore Partners acquisition.
Positive Outlook
- Improved U.S. Healthcare adjusted operating income
- Continued cost savings in U.S. Retail Pharmacy
- Boots.com sales grew 18.7%
- Free cash flow remained positive
- Shields and CareCentrix showed sales growth
Challenges Ahead
- U.S. retail sales declined
- Higher tax expenses impacted earnings
- Lower equity earnings in Cencora
- No forward guidance provided
- Net loss driven by lack of prior-year one-time gains
Revenue & Expenses
Visualization of income flow from segment revenue to net income